SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 19, 16:30
617.45
-3.1 (-0.5%)
VOLUME 45,990
LIVE
NSE
Dec 19, 16:30
617.95
-2.3 (-0.37%)
VOLUME 665,598
Earnings News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Merger with Ranbaxy might get delayed: Sun CFO Baldota 

11.59 am | 14 Nov 2014 |  Source: CNBC-TV18

The pharma major is hopeful of maintaining its revenue growth guidance of 13-15 percent for FY15 though the margins may get impacted marginally....

US core business continues to be a drag for Ranbaxy: CIMB 

9.05 am | 29 Oct 2014 |  Source: CNBC-TV18

Prakash Agarwal, Equity Analyst, CIMB has a hold rating on Ranbaxy with target price of Rs 630/share. ...

Here's how experts read Ranbaxy's Q2FY15 earnings

3.59 pm | 28 Oct 2014 |  Source: CNBC-TV18

Ranbaxy Laboratories has turned profitable in the second quarter of current financial year. The company reported consolidated net profit of Rs 478 cro...

Ranbaxy turns corner, Q2 net at Rs 478 cr; OPM up 1770 bps 

2.02 pm | 28 Oct 2014 |  Source: Moneycontrol.com

The company reported consolidated net profit of Rs 478 crore during the quarter as against loss of Rs 454 crore in the year-ago period....

AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

3.31 pm | 31 Jul 2014 |  Source: Reuters

On the back of the strong results, AstraZeneca raised its guidance for the full year, predicting sales would hold steady and not decline as previously...

Dr Reddy's, Lupin, Glenmark top pharma bets: Nomura 

11.25 am | 31 Jul 2014 |  Source: CNBC-TV18

"We have a buy recommendation on both Sun Pharma and Ranbaxy at this point," Saion Mukherjee, research analyst Nomura said....

Ranbaxy Q1 disappoints, posts loss at Rs 186cr on provision 

5.14 pm | 29 Jul 2014 |  Source: CNBC-TV18

Consolidated revenue of the company fell 9.6 percent on yearly basis to Rs 2,426.2 crore due to lower exports (declined over 13 percent) while domesti...

Ranbaxy Labs may post Q1 profit Rs 27 cr vs loss YoY: Poll 

6.15 pm | 28 Jul 2014 |  Source: CNBC-TV18

Analysts feel operating profit (EBITDA) may be impacted due to consent decree costs that is expected to be in single digits. They expect mark-to-marke...

1
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.